Femara 2.5 MG Oral Tablet

RxCUI: 153124
RxNorm name: Femara 2.5 MG Oral Tablet
Display name: Femara 2.5 MG Oral Tablet
Full name: Femara 2.5 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KISQALI FEMARA CO-PACK	LETROZOLE AND RIBOCICLIB	Novartis Pharmaceuticals Corporation	aa5e4446-19cd-4235-a382-5b48bf6c3b2f	2026-07-01	Warnings, Adverse reactions	Exact identifier rxcui: 153124
Femara	LETROZOLE	Novartis Pharmaceuticals Corporation	82b77d74-085f-45ac-a7dd-1f5c038bf406	2026-06-11	Warnings, Adverse reactions	Exact identifier rxcui: 153124

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
82b77d74-085f-45ac-a7dd-1f5c038bf406	Femara 2.5 MG Oral Tablet [PSN] · letrozole 2.5 MG Oral Tablet [Femara] [SBD] · Femara 2.5 MG Oral Tablet [SY]	3	31	These highlights do not include all the information needed to use FEMARA safely and effectively. See full prescribing information for FEMARA. FEMARA (letrozole) tablets, for oral use Initial U.S. Approval: 1997	20250821
aa5e4446-19cd-4235-a382-5b48bf6c3b2f	Femara 2.5 MG Oral Tablet [PSN] · letrozole 2.5 MG Oral Tablet [Femara] [SBD] · Femara 2.5 MG Oral Tablet [SY]	3	25	These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 2017	20250916
e11b0a54-92bd-4790-8b80-f439f7093c01	Femara 2.5 MG Oral Tablet [PSN] · letrozole 2.5 MG Oral Tablet [Femara] [SBD] · Femara 2.5 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use Femara safely and effectively. See full prescribing information for Femara. Femara (letrozole ) ta blets Initial U.S. Approval: 1997	20120109